Reagents and instruments for immunology, cell biology and molecular biology.

APExBIO Technology

APExBIO. As a premier provider of small molecule inhibitors/activators, compound libraries, peptides, assay kits, fluorescent labels, enzymes, modified nucleotides, and various tools for molecular biology, APExBIO empowers researchers to achieve perfection and explore the unknown. Here are some highlights:

Product Range: APExBIO offers a wide range of featured products, including compound libraries, fluorescent labels, enzymes, and modified nucleotides. They cover over 1,000 inhibitors/activators across 23 signaling pathways from various research areas.
Signaling Pathways: Detailed signaling pathway maps highlight the latest research progress, making it easier for scientists to navigate their offerings.

Website: www.apexbt.com

SARS-CoV-2 - Secondary antibodies for research and development

The current COVID-19 pandemic has sickened more than 520,000 people worldwide and continues to increase daily. There is an urgent need to increase current diagnostic capacity. Compared to the commonly used PCR test, the diagnostic method based on the serological test is much easier and faster to perform. To support the development of immunodiagnostic methods, we offer a comprehensive collection of antibodies and antigens for SARS-CoV-2.

We offer a full range of antibodies to human IgG and IgM for research and development of kits for the detection of anti-SARS-CoV-2 antibodies in patient samples.

Rapid tests for the screening of COVID-19 affected patients, based on the principle of immunochromatography, use anti-human IgG and IgM antibodies to detect anti-SARS-CoV-2 antibodies produced by patients in serum, plasma or whole blood samples.